Sciencetragedy of the commonsanticommons science-361-6400-anticommons-research The anticommons at 20: Concerns for research continue Several factors could explain the absence of pooling in this arena: the need for at least some market exclusivity in an environment with extremely high costs of product development, clinical trials, and regulatory approval; patent holders’ desire to retain control over their assets; and concerns over compromising commercial secrecy by collaborating with others. By Jorge L. Contreras Jul 25th, 2018 Previous Next
